简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2021-02-23 11:55 Online Symposium by JETRO - Future Society After the Pandemic, Expectations for EXPO 2025, and the Potential of the Osaka Kansai Region
2021-02-23 09:26 LG Chem Life Sciences Announces First Participant Dosed in First-in-Human Study of SSAO Inhibitor LG00303174 in the United States
2021-02-23 09:18 Smiths Detection’s BioFlash shown to detect airborne COVID-19
2021-02-22 09:05 Final Data From the NuProtect Study Published on the Immunogenicity of Nuwiq® in Previously Untreated Patients With Severe Haemophilia A
2021-02-20 18:06 HCL Foundation Continues Commitment to Enhance Rural Lives; Announces INR 16.5 Crore ($2.27 Million) Grant to NGOs in Sixth Edition of HCL Grant
2021-02-19 14:57 Patient Safety Movement Foundation Announces Winners of 2020 Humanitarian Awards
2021-02-19 09:38 Kaneka Eurogentec Receives GMP Accreditation for New mRNA Manufacturing Facility – COVID-19 Vaccine Production Ongoing
2021-02-18 18:45 Global Investors Accelerate ESG Investments in Response to Pandemic, According to MSCI Survey; Interconnected Risks Present Challenges
2021-02-18 09:32 Launch of ESMO Virtual Plenaries Brings Rapid Access to Ground-breaking Cancer Research
2021-02-18 09:29 Ferring, Rebiotix and MyBiotics Collaborate to Develop Live Microbiome-Based Therapeutics in Reproductive Medicine and Maternal Health
2021-02-18 09:04 SETi and Seoul Viosys Develop Portable 'Photon Stand' Surface Disinfection Unit That Kills Viruses in 10 Minutes
2021-02-18 08:49 Takeda’s Maribavir Phase 3 Clinical Trial Met Primary Endpoint of Superiority to Conventional Antiviral Therapy in Transplant Recipients With Refractory, With or Without Resistance, Cytomegalovirus Infection/Disease
2021-02-18 08:46 Modra Pharmaceuticals Presents Preliminary Data from Phase IIb Trial of ModraDoc006/r in Metastatic Prostate Cancer at 2021 ASCO GU Annual Meeting
2021-02-10 19:00 GNT Pharma’s GedaCure® Approved for the Treatment of Dogs With Cognitive Dysfunction Syndrome
2021-02-10 15:07 Rhizen Pharmaceuticals AG Announces That Its Partnered Asset, Umbralisib (UKONIQ™), Has Received US FDA Accelerated Approval for Adult Patients With Relapsed or Refractory MZL & FL
2021-02-10 15:00 Takeda Submits New Drug Application to Manufacture and Market Darvadstrocel In Japan for Treatment of Complex Perianal Fistulas in Adult Patients with Crohn’s Disease
2021-02-10 10:23 MED™ 3D Printed Pharmaceutical Product Receives IND Clearance From the US FDA
2021-02-09 16:10 IntelliCentrics Debuts Healthcare’s First COVID-19 Credential
2021-02-09 10:46 Takeda FY2020 Q3 Results Demonstrate Growth Acceleration and Continued Resilience; Full-Year Management Guidance for FY2020 Confirmed, Forecast Raised for Free Cash Flow and Reported EPS
2021-02-08 18:22 Healthcare Ventures Has Launched a Venture Capital Fund, Dedicated to Digital Health

Business Wire Weibo

Press Releases

Latest Releases